dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
AR2_1059 | ED149372 | General Research Use | No | Female | Black or African American | 66 | 5 - AREDS AMD Severity Scale Step 5 | 5 - AREDS AMD Severity Scale Step 5 |
AR2_1694 | ED149161 | General Research Use | No | Female | Black or African American | 70 | 6 - AREDS AMD Severity Scale Step 6 | 5 - AREDS AMD Severity Scale Step 5 |
AR2_4105 | ED149265 | General Research Use | No | Male | Black or African American | 68 | 4 - AREDS AMD Severity Scale Step 4 | 5 - AREDS AMD Severity Scale Step 5 |
AR2_1168 | ED149425 | General Research Use | No | Female | Black or African American | 68 | 7 - AREDS AMD Severity Scale Step 7 | 8 - AREDS AMD Severity Scale Step 8 |
AR2_1311 | ED148140 | General Research Use | No | Female | Black or African American | 62 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
AR2_2561 | ED149744 | General Research Use | No | Male | Black or African American | 59 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
AR2_3368 | ED149332 | General Research Use | No | Female | Black or African American | 64 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
AR2_3390 | ED149854 | General Research Use | No | Male | Black or African American | 66 | 7 - AREDS AMD Severity Scale Step 7 | 6 - AREDS AMD Severity Scale Step 6 |
AR2_0006 | ED149042 | General Research Use | No | Female | Black or African American | 62 | 6 - AREDS AMD Severity Scale Step 6 | 6 - AREDS AMD Severity Scale Step 6 |
AR2_0526 | ED149770 | General Research Use | No | Male | Black or African American | 61 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
AR2_0699 | ED149860 | General Research Use | No | Male | Black or African American | 61 | 7 - AREDS AMD Severity Scale Step 7 | 5 - AREDS AMD Severity Scale Step 5 |
AR2_0904 | ED148841 | General Research Use | No | Female | Black or African American | 67 | 6 - AREDS AMD Severity Scale Step 6 | 6 - AREDS AMD Severity Scale Step 6 |
AR2_0956 | ED149371 | General Research Use | No | Female | Black or African American | 57 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
AR2_2038 | ED149945 | General Research Use | No | Male | Black or African American | 64 | 5 - AREDS AMD Severity Scale Step 5 | 6 - AREDS AMD Severity Scale Step 6 |
AR2_2068 | ED148446 | General Research Use | No | Female | Black or African American | 68 | 7 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
AR2_2323 | ED148511 | General Research Use | No | Female | Black or African American | 79 | 6 - AREDS AMD Severity Scale Step 6 | 6 - AREDS AMD Severity Scale Step 6 |
AR2_3256 | ED148493 | General Research Use | No | Female | Black or African American | 62 | 1 - AREDS AMD Severity Scale Step 1 | 3 - AREDS AMD Severity Scale Step 3 |
AR2_2644 | ED148178 | General Research Use | No | Female | Black or African American | 68 | 6 - AREDS AMD Severity Scale Step 6 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
AR2_2875 | ED148485 | General Research Use | No | Male | Black or African American | 75 | 7 - AREDS AMD Severity Scale Step 7 | 8 - AREDS AMD Severity Scale Step 8 |
AR2_4124 | ED149293 | General Research Use | No | Male | Black or African American | 50 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |